Meggle’s business group, Excipients and Technology, has appointed Alexander Torster, MBA, as its new head of sales and marketing.
Vetter, CDMO specializing in aseptic manufacturing, announced that the company’s advisory board has appointed Oliver Albrecht as a new managing director effective from April 1, 2015. Albrecht replaces Max Horn as Vetter’s managing director who left the company in June 2014.
Oliver Albrecht has more than 20 years of experience managing international, medium-sized listed companies both as a managing director and as a chief financial officer in various industries including banking, automotive, and mechanical engineering. In recent years, he was the chief financial officer for SHW AG headquartered in Aalen, Germany and also acted as an independent consultant for mid-sized companies.
Albrecht’s previous positions include senior posts at companies such as chief financial officer for centrotherm photovoltaics AG and director in the financial and banking sector. He holds a diploma in business from the University of Mannheim, Germany.
In his new role as managing director at Vetter, Albrecht will be responsible for two of the eight company divisions, the first of which is comprised of finance, controlling, and IT. The second division includes corporate development, legal, and corporate compliance.
Source: Vetter
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.